Cargando…
The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies
BACKGROUND: CYP2E1 encodes a member of the cytochrome P450 superfamily of enzymes which play a central role in activating and detoxifying many carcinogens and endogenous compounds thought to be involved in the development of cancer. The PstI/RsaI and DraI polymorphism are two of the most commonly st...
Autores principales: | Tang, Kefu, Li, Yang, Zhang, Zhao, Gu, Yunmin, Xiong, Yuyu, Feng, Guoyin, He, Lin, Qin, Shengying |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988025/ https://www.ncbi.nlm.nih.gov/pubmed/20969746 http://dx.doi.org/10.1186/1471-2407-10-575 |
Ejemplares similares
-
Functional PstI/RsaI Polymorphism in CYP2E1 Is Associated with the Development, Progression and Poor Outcome of Gastric Cancer
por: Feng, Jin, et al.
Publicado: (2012) -
RsaI but not DraI polymorphism in CYP2E1 gene increases the risk of gastrointestinal cancer in Malaysians: a case–control study
por: Chong, Eric Tzyy Jiann, et al.
Publicado: (2014) -
CYP2E1 RsaI/PstI Polymorphism and Gastric Cancer Susceptibility: Meta-Analyses Based on 24 Case-Control Studies
por: Zhuo, Wenlei, et al.
Publicado: (2012) -
Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies
por: Zhuo, Xianlu, et al.
Publicado: (2016) -
Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies
por: LENG, WEI-DONG, et al.
Publicado: (2012)